Nuzenio

Oral Kras

Oral Kras entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 2 latest news signals 2 publisher sources 100/100 entity strength

Timeline

Mon, 10 Aug 2026 10:33:20 GMTGenfleet becomes first to test oral KRAS G12D inhibitor in Phase III for NSCLC - AllSci
Tue, 28 Jul 2026 07:00:00 GMTVerastem Oncology Doses First Patient in TARGET-D 203 Phase 2 Registration-Directed Trial of VS-7375 Oral KRAS G12D (ON/OFF) Inhibitor for KRAS G12D-Mutated Metastatic Colorectal Cancer - Yahoo Finance

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Oral Kras.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

2 distinct publisher/source names are currently connected to this entity page.